Keros Therapeutics shares owned by J. Goldman & Co
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by J. Goldman & Co
from 13F filings
Historical chart of J. Goldman & Co investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by J. Goldman & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.4M | 30k | 45.70 |
| 2023-12-31 | $231k | 5.8k | 39.76 |
| 2023-06-30 | $309k | 7.7k | 40.18 |
| 2023-03-31 | $313k | 7.3k | 42.70 |
| 2022-12-31 | $1.2M | 24k | 48.02 |
| 2022-09-30 | $2.4M | 62k | 37.67 |